Article Text

Download PDFPDF
Tackling osteoarthritis during COVID-19 pandemic
  1. Francisco Airton Castro da Rocha1,
  2. Lucas da Ponte Melo1,2,
  3. Francis Berenbaum3
  1. 1 Internal Medicine, Faculdade de Medicina da Universidade Federal do Ceara, Fortaleza, Brazil
  2. 2 Departamento de Ortopedia e Traumatologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
  3. 3 Department of Rheumatology, AP-HP Saint-Antoine Hospital, Sorbonne Universite, Paris, Île-de-France, France
  1. Correspondence to Dr Francis Berenbaum, Department of rheumatology, AP-HP Saint-Antoine hospital, Sorbonne Universite, 75012 Paris, Île-de-France, France; francis.berenbaum{at}aphp.fr

Abstract

In this opinion article, we would like to draw attention to the fact that COVID-19 has a significant impact not only on immune-mediated arthritis but also on osteoarthritis (OA), the most common rheumatic disease. We suggest herein strategies for pain relief and symptom prevention in patients with OA during COVID-19 pandemic.

  • osteoarthritis
  • epidemiology
  • analgesics

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Handling editor Josef S Smolen

  • Twitter @larhumato

  • Contributors All authors contributed to this response to correspondence and approved the final version.

  • Funding Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ), Brasil – Grant 308429/2018–4.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.